logo

For the Inventor, By the Inventor

Redwood City, CA, United States of America

Sentreheart, Inc.


USPTO Granted Patents = 41

% Expired Patents = 12.2



Trademarks = 5

Forward Citations = 1,101

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Gregory W Fung (27 out of 35 patents)

silverMedal Russell A Seiber (17 out of 20 patents)

bronzeMedal Arnold M Escano (16 out of 49 patents)

4.  Robert L Clark, Iii (13 out of 48 patents)

5.  William Ettlinger Cohn (10 out of 61 patents)

6.  Russell Pong (10 out of 13 patents)

7.  John R Liddicoat (9 out of 49 patents)

8.  Ryan Douglas Helmuth (8 out of 9 patents)

9.  Gary Henry Miller (8 out of 36 patents)

10.  Roger Laham (7 out of 11 patents)

11.  Alan L Bradley (5 out of 8 patents)

12.  Aaron V Kaplan (5 out of 72 patents)

13.  Eduardo Sager, Jr (4 out of 6 patents)

14.  Greg Liu (3 out of 25 patents)

15.  Maria Garcia (3 out of 4 patents)


Core Competencies:
Tissue Ligation
Left Atrial Appendage Closure
Pericardial Access
Atrial Fibrillation Treatment
Suture Management
Tensioning Devices
Lead Placement
Device Delivery

41 patents:

1. 11350944 - Apparatus and method for the ligation of tissue (2022-06-07),
2. 11224435 - Devices and Methods for left atrial appendage closure (2022-01-18),
3. 11207073 - Tissue ligation devices and methods therefor (2021-12-28),
4. 11026690 - Tissue ligation devices and tensioning devices therefor (2021-06-08),
5. 11020122 - Methods for closing the left atrial appendage (2021-06-01),
6. 10966725 - Devices and systems for closing the left atrial appendage (2021-04-06),
7. 10959752 - Pericardial access devices and methods (2021-03-30),
8. 10959734 - Tissue ligation devices and methods therefor (2021-03-30),
9. 10806460 - Apparatus and method for the ligation of tissue (2020-10-20),
10. 10799288 - Devices and methods for left atrial appendage closure (2020-10-13),
11. 10799241 - Tissue ligation devices and controls therefor (2020-10-13),
12. 10716571 - Devices and methods for left atrial appendage closure (2020-07-21),
13. 10405919 - Methods and devices for treating atrial fibrillation (2019-09-10),
14. 10327780 - Apparatus and method for the ligation of tissue (2019-06-25),
15. 10292710 - Devices and methods for left atrial appendage closure (2019-05-21),
Company Overview
Sentreheart, Inc. is a medical device company based in Redwood City, California, specializing in innovative solutions for cardiac procedures. The organization focuses on developing advanced technologies for tissue ligation and left atrial appendage closure, particularly in the context of atrial fibrillation treatment. Their expertise extends to pericardial access devices, transpericardial closure techniques, and remote suture management, aiming to enhance the safety and efficacy of cardiac interventions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Sentreheart, Inc. USPTO Patent Assignee Logo
41 Patents

#54 in Redwood City, CA

#1,991 in California

#8,447 in US

#16,725 in the World

Redwood City, CA (US)
Redwood City, CA, United States of America

Sentreheart, Inc.

Forward Citations = 1,101

21 inventors:

goldMedal Gregory W Fung (27 out of 35 patents)

silverMedal Russell A Seiber (17 out of 20 patents)

bronzeMedal Arnold M Escano (16 out of 49 patents)

4.  Robert L Clark, Iii (13 out of 48 patents)

5.  William Ettlinger Cohn (10 out of 61 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sentreheart, Inc.. Retrieved from https://idiyas.com/company/sentreheart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…